Cellectis (CLLS) Cost of Revenue (2018 - 2023)
Cellectis' Cost of Revenue was -$344,000 in Q4 2023, compared with $690,000 a year earlier.
Powered by 
Analysis
Cellectis (CLLS) Cost of Revenue (2018 - 2023) Analysis & Trends
For FY2023, Cost of Revenue at Cellectis came in at $737,000, down 58.4% from FY2022.
- Cost of Revenue has now declined for three consecutive years, though with a five-year compound annual growth rate of 4.4% (FY2018 to FY2023).
- In earlier years, Cost of Revenue was $1.77 million in FY2022 (-3.9%), $1.84 million in FY2021 (-94.6%), $34.32 million in FY2020 (+201.3%) and $11.39 million in FY2019.
- The Q4 2023 figure marks the lowest quarterly Cost of Revenue in data going back to Q1 2018.
- Compared with a year earlier, Cost of Revenue was higher in 1 of the last seven quarters, with an average decline of 28.7%.
- The best year-over-year quarter for Cost of Revenue over five years was Q4 2019 (growth of 685.0%); the worst was Q4 2021 (a decline of 98.7%).
- Per Business Quant data, CLLS's Cost of Revenue in the three quarters before Q4 2023 was $367,000 (Q3 2023), $55,000 (Q2 2023) and $334,000 (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Cellectis | 143.49 Mn | -609.91 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -344,000.00 |
| Sep 30, 2023 | 367,000.00 |
| Jun 30, 2023 | 55,000.00 |
| Mar 31, 2023 | 334,000.00 |
| Dec 31, 2022 | 690,000.00 |
| Sep 30, 2022 | 367,000.00 |
| Jun 30, 2022 | 329,000.00 |
| Mar 31, 2022 | 385,000.00 |
| Dec 31, 2021 | 243,000.00 |
| Sep 30, 2021 | 9.21 Mn |
| Jun 30, 2021 | 11.75 Mn |
| Mar 31, 2021 | 8.15 Mn |
| Dec 31, 2020 | 18.64 Mn |
| Sep 30, 2020 | 7.82 Mn |
| Jun 30, 2020 | 5.83 Mn |
| Mar 31, 2020 | 4.60 Mn |
| Dec 31, 2019 | 5.65 Mn |
| Sep 30, 2019 | 4.26 Mn |
| Jun 30, 2019 | 815,000.00 |
| Mar 31, 2019 | 586,000.00 |
API Access
Cellectis Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=CLLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();